TY - JOUR T1 - Sialylation of Human Thyrotropin Receptor Improves and Prolongs Its Cell-Surface Expression JF - Molecular Pharmacology JO - Mol Pharmacol SP - 1106 LP - 1113 DO - 10.1124/mol.105.012906 VL - 68 IS - 4 AU - Romy Frenzel AU - Knut Krohn AU - Markus Eszlinger AU - Anke Tönjes AU - Ralf Paschke Y1 - 2005/10/01 UR - http://molpharm.aspetjournals.org/content/68/4/1106.abstract N2 - Glycosylation of the thyrotropin receptor (TSHR) has been shown to be essential for correct protein folding and for cell-surface targeting. In a recent study, we detected increased expression of β-galactoside α(2,6)-sialyltransferase (SIAT1) in toxic thyroid adenomas where gain-of-function mutations of the TSHR have been invoked as one of the major causes. To investigate the physiological meaning of these findings, we designed experiments to evaluate the consequences of sialylation for the expression of the TSHR. Hence, we investigated the effect of coexpressing the TSHR and different sialyltransferases (SIAT1, SIAT4a, and SIAT8a) for cell-surface expression of the receptor. Coexpression of each of the three SIAT isoforms and the TSHR in COS-7 cells increased TSHR expression on the cell surface in the range of 50 to 100%. Moreover, Western blot analysis with lectins specific for α(2,3) and α(2,6)-linked sialic acids and lectin-binding enzyme-linked immunosorbent assay support a direct effect on TSHR cell-surface expression mediated by sialic acid transfer to the TSHR. Finally, we treated living COS-7 cells after cotransfection of TSHR and SIAT8a with neuraminidase for 30 min to remove covalently linked sialic acid. Subsequent loss of TSHR cell-surface expression suggests that sialylation prolongs the resting time of the TSHR on the cell surface. Our data demonstrate for the first time that the transfer of sialic acid can improve and prolong cell-surface expression of a transmembrane receptor. ER -